Our value proposition for CRO/CMDO companies​

​​

​Accelerated patient recruitment and retention:
Turmerik’s AI-powered platform streamlines patient matching, reducing recruitment timelines and bringing drugs to market faster. It identifies ideal candidates from diverse populations, including those who may become eligible with additional tests, expanding the recruitment pool and enhancing trial diversity.

​

Protocol generation:
Turmerik’s AI-powered platform assists in creating trial protocols by automating document preparation, ensuring regulatory compliance, and tailoring designs to specific study needs. This reduces setup time and minimizes human error in protocol development and simplify complex regulatory processes to meet regional requirements seamlessly.

​

Site selection:

By analyzing structured and unstructured health data, Turmerik identifies ideal trial sites with the necessary infrastructure, patient demographics, and clinical expertise. Predictive analytics provide accurate estimates of enrollment rates and site activation timelines, ensuring efficient and targeted site selection for clinical trials.